AAM
EW icon

Aston Asset Management’s Edwards Lifesciences EW Stock Holding History

Aston Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-53,142
Closed -$905K – 142
2014
Q3 		$905K Sell
53,142
-89,928
-63% -$1.42M 0.21% 102
2014
Q2 		$2.05M Sell
143,070
-118,554
-45% -$1.61M 0.47% 79
2014
Q1 		$3.23M Buy
261,624
+27,156
+12% +$313K 0.76% 51
2013
Q4 		$2.57M Buy
+234,468
New +$2.64M 0.63% 60

Other funds holding EW

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aston Asset Management's EW Position: Q4 2014 in Review

Aston Asset Management sold out of Edwards Lifesciences (EW) in Q4 2014, closing a stake of 53,142 shares — an estimated $905K sold.

Aston Asset Management first reported a position in EW in Q4 2013 and held it in 4 quarters. The position peaked at $3.23M in Q1 2014. 556 funds tracked by Wall St. Rank hold EW as of Q4 2014.

  • Aston Asset Management reported no remaining Edwards Lifesciences position as of Q4 2014 after selling out during the quarter.
  • Aston Asset Management sold 53,142 Edwards Lifesciences shares in Q4 2014, an estimated $905K.
  • Aston Asset Management first reported a position in Edwards Lifesciences in Q4 2013 and held it in 4 quarters.
  • Aston Asset Management's Edwards Lifesciences position peaked at $3.23M in Q1 2014.
  • 556 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2014.

Based on Aston Asset Management's 13F filing for Q4 2014, filed 12 Feb 2015.